{"transactions":[{"id":1791155,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true}}],"security":"Series Y Preferred Stock","published_at":"2023-09-01T20:07:08.000Z","date":"2023-08-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":28.228,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 20, 2023, the Company's board of directors (the \"Board\") declared a dividend of one one-thousandth of a share of Series Y Preferred Stock, par value $0.001 per share (the \"Preferred Stock\"), for each outstanding share of common stock to common stockholders of record at 5:00 p.m. Eastern Time on June 30, 2023, in a transaction exempt from Section 16 under Rule 16a-9. The shares of Preferred Stock were distributed on June 30, 2023. As a result, the Reporting Person received the shares of Preferred Stock set forth above. The Preferred Stock was not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of the Company."},{"field":"shares","element":"transactionShares","label":"F2","text":"On August 31, 2023, the Company filed, as approved by the Board, a certificate of elimination with the Secretary of State of the State of Delaware pursuant to which the outstanding shares of the Preferred Stock were eliminated."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 31, 2023, the Company filed, as approved by the Board, a certificate of elimination with the Secretary of State of the State of Delaware pursuant to which the outstanding shares of the Preferred Stock were eliminated."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-23-042368","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036123042368/form4.xml","form_type":"4"}},{"id":2440383,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-07T22:30:34.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":7521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":28228,"source":{"system":"sec-edgar","filing":"0001209191-22-002482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919122002482/doc4.xml","form_type":"4"}},{"id":2549692,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-05T20:32:42.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":1824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":20707,"source":{"system":"sec-edgar","filing":"0001209191-21-059427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121059427/doc4.xml","form_type":"4"}},{"id":2645472,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T13:53:24.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option will vest and become exercisable on June 9, 2022, the one-year anniversary of the grant date."}],"balance_after":14000,"derivative":{"exercise_price":4.55,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-21-044689","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121044689/doc4.xml","form_type":"4"}},{"id":2645471,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T13:53:24.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":2886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":18883,"source":{"system":"sec-edgar","filing":"0001209191-21-044689","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121044689/doc4.xml","form_type":"4"}},{"id":2758533,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-05T17:37:56.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":2480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":15997,"source":{"system":"sec-edgar","filing":"0001209191-21-025030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121025030/doc4.xml","form_type":"4"}},{"id":2916332,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-06T21:56:46.000Z","date":"2021-01-05","kind":"grant","acquired":true,"shares":1881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":13517,"source":{"system":"sec-edgar","filing":"0001209191-21-002161","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919121002161/doc4.xml","form_type":"4"}},{"id":3016733,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-02T20:18:04.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":2761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":11636,"source":{"system":"sec-edgar","filing":"0001209191-20-053119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120053119/doc4.xml","form_type":"4"}},{"id":3092610,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T20:42:44.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":2076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":8875,"source":{"system":"sec-edgar","filing":"0001209191-20-040386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120040386/doc4.xml","form_type":"4"}},{"id":3112133,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-12T20:45:36.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest monthly over a period of 12 months commencing June 11, 2020."}],"balance_after":5000,"derivative":{"exercise_price":7.18,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-20-036312","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120036312/doc4.xml","form_type":"4"}},{"id":3183957,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-03T20:39:48.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":1673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of fees."}],"balance_after":6799,"source":{"system":"sec-edgar","filing":"0001209191-20-023182","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120023182/doc4.xml","form_type":"4"}},{"id":3327525,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-02T21:45:00.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":1073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of stock received in lieu of fees."}],"balance_after":5126,"source":{"system":"sec-edgar","filing":"0001209191-20-000337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919120000337/doc4.xml","form_type":"4"}},{"id":3401373,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-02T20:07:36.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":1489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of stock received in lieu of fees."}],"balance_after":4053,"source":{"system":"sec-edgar","filing":"0001209191-19-051614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119051614/doc4.xml","form_type":"4"}},{"id":3471773,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-02T20:49:57.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":1036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of stock received in lieu of fees."}],"balance_after":2564,"source":{"system":"sec-edgar","filing":"0001209191-19-040358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119040358/doc4.xml","form_type":"4"}},{"id":3488283,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-18T01:08:46.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest monthly over a period of 12 months commencing June 13, 2019."}],"balance_after":5000,"derivative":{"exercise_price":7.46,"exercise_date":"2020-06-13","expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-037568","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119037568/doc4.xml","form_type":"4"}},{"id":3569351,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-02T20:37:20.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of stock received in lieu of fees."}],"balance_after":1528,"source":{"system":"sec-edgar","filing":"0001209191-19-022530","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119022530/doc4.xml","form_type":"4"}},{"id":3709616,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-03T22:44:20.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":811,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of stock received in lieu of fees."}],"balance_after":811,"source":{"system":"sec-edgar","filing":"0001209191-19-001219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919119001219/doc4.xml","form_type":"4"}},{"id":3892772,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T21:53:15.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest monthly over a period of 12 months commencing June 13, 2018."}],"balance_after":5000,"derivative":{"exercise_price":24.94,"exercise_date":"2019-06-13","expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-038136","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118038136/doc4.xml","form_type":"4"}},{"id":4180163,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":110054,"kind":"person","name":"Hunt Andrea","position":1,"cik":"0001720487","reported_name":"Hunt Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-27T01:28:53.000Z","date":"2017-10-25","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option shall vest monthly over a period of three years commencing October 25, 2017."}],"balance_after":10000,"derivative":{"exercise_price":4.72,"expiration_date":"2027-10-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-058099","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919117058099/doc4.xml","form_type":"4"}}]}